Neutralizing Anti-IL20 Antibody Treatment Significantly Modulates Low Grade Inflammation without Affecting HbA1c in Type 2 Diabetic db/db Mice

por Mayer, Christopher, Bergholdt, Regine, Cucak, Helena, Rolin, Bidda Charlotte, Sams, Anette, Rosendahl, Alexander
Publicado 2015